Breast Cancer Screening, Prevention & In...

This week’s episode we are very excited to welcome back our special guest Dr. Hatim Husain, MD, a medical oncologist and physician-scientist at UC San Diego Moores Cancer Center, whose clinical and research expertise focuses on lung cancer and precision oncology. We further cover ... Show More

This week’s episode we are very excited to welcome a special guest Dr. Hatim Husain, MD, a medical oncologist and physician-scientist at UC San Diego Moores Cancer Center, whose clinical and research expertise focuses on lung cancer and precision oncology. We cover the topic of l ... Show More

This week's episode focuses on metastatic non-small cell lung cancer - the quickly growing and changing systemic therapy landscape, including traditional chemotherapy, immunotherapy, and targeted agents. Since our last recording the number of FDA-approved targeted drugs has signi ... Show More

<p class="" style="white-space:pre-wrap;">In this continuation of our myeloma series, we discuss the progression of MGUS &amp; smoldering myeloma to multiple myeloma. We also outline how to risk stratify a patient with multiple myeloma and gauge their response to treatment.&nbsp; ... Show More

<p class="" style="white-space:pre-wrap;">In this continuation of our myeloma series, we build on our prior discussion about myeloma pharmacology, this time discussing how to select the optimal regimen for treatment of our patients.</p><p class="" style="white-space:pre-wrap;">Co ... Show More

<p>In this episode I cover myeloma.<br/><br/>If you want to follow along with written notes on myeloma go to <a href='https://zerotofinals.com/medicine/haematology/myeloma/'>zerotofinals.com/medicine/haematology/myeloma/</a> or the haematology section in the Zero to Finals medici ... Show More

Send us Fan MailNinja Nerds!Welcome to the Ninja Nerd Podcast with Zach and Rob! In this episode, we take a closer look at Plasma Cell Disorders, focusing on their pathophysiology, clinical features, and management. Topics include the mechanisms behind multiple myeloma, monoclona ... Show More

<p>This episode covers myeloma.<br/><br/>Written notes can be found at <a href='https://zerotofinals.com/medicine/haematology/myeloma/'>https://zerotofinals.com/medicine/haematology/myeloma/</a> or in the haematology section of the 2nd edition of the Zero to Finals medicine book. ... Show More

In this week's episode, we’ll learn more about mechanisms of primary resistance to BCMA-targeted bispecific T-cell engagers in relapsed/refractory multiple myeloma, the effects of emapalumab therapy on outcomes in patients with pediatric hemophagocytic lymphohistiocytosis who rec ... Show More

<p class="" style="white-space:pre-wrap;">In this continuation of our myeloma series, we discuss all the key principles and data surrounding autologous stem cell transplant in myeloma. We provide a succinct summary of key trials in this space that will give you a deep understandi ... Show More

<p class="" style="white-space:pre-wrap;">In this continuation of our myeloma series, we begin our discussion about treatment options for multiple myeloma, focusing first on pharmacology. We are so thrilled to have a special guest, Kathryn Maples, PharmD, BCOP who is a clinical p ... Show More

<p>In this week’s episode, we discuss the diagnostic criteria and risk stratification for myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML), building on our discussion from last week. Also, if you have not done so, please do check out our hemepath series to ensure y ... Show More